Burri Haran
Cardiology Department, University Hospital of Geneva, Geneva, Switzerland.
Arrhythm Electrophysiol Rev. 2017 Aug;6(3):109-110. doi: 10.15420/aer.2017:10:1.
In the era of communication technology, remote monitoring has been a paradigm shift in the way patients with cardiac implantable electronic devices are managed. It has been endorsed by scientific societies and is being increasingly adopted in the clinical setting. Despite the various advantages associated with this strategy, data on improved clinical outcome are still sparse. The recently published study on the remote management of heart failure using implanted devices and formalised follow-up procedures, which turned out to be negative, has cast doubt on whether remote monitoring should still be used. This article provides a critical appraisal of the study, and discusses the issue of remote data management.
在通信技术时代,远程监测已成为心脏植入式电子设备患者管理方式的一种范式转变。它已得到科学协会的认可,并在临床环境中越来越多地被采用。尽管这种策略有诸多优点,但关于改善临床结局的数据仍然稀少。最近发表的一项关于使用植入设备和规范化随访程序进行心力衰竭远程管理的研究结果为阴性,这让人怀疑是否仍应使用远程监测。本文对该研究进行了批判性评估,并讨论了远程数据管理问题。